Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions [1]

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 1, 2001, Pages 196-197

  Remitz, A ^a   Kyllonen H ^a   Granlund, H ^a   Reitamo, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; IMMUNOGLOBULIN E RECEPTOR; SUPERANTIGEN; TACROLIMUS; VIRUS ANTIGEN;

ADULT; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BACTERIUM COLONY; CLINICAL ARTICLE; CLINICAL TRIAL; ECZEMA; FEMALE; HUMAN; IMMUNOMODULATION; LANGERHANS CELL; LETTER; LONG TERM CARE; MALE; MULTICENTER STUDY; OINTMENT; PRIORITY JOURNAL; SKIN DEFECT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SUPERINFECTION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 0035144821     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.112131     Document Type: Letter

References (7)

1. Bacteriology of atopic dermatitis
2. Local steroid therapy and bacterial skin flora in atopic dermatitis
3. A short-term trial of tacrolimus (FK506) ointment for atopic dermatitis
4. Safety and efficacy of 1 year of tacrolimus ointment in adults with atopic dermatitis
5. Tacrolimus ointment for atopic dermatitis
6. FK-506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation, and physio-chemical and biological characteristics
7. Atopic dermatitis: New insights and opportunities for therapeutic intervention